3 completed. 3 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 3 |
Follow Recurrent Hematologic Malignancy: new trials by email Literature Review of Recurrent Hematologic Malignancy trials Research Report on Recurrent Hematologic Malignancy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Flotetuzumab for the Treatment of Relapsed or Refractory Advanced CD123-Positive Hematological Malignancies Acetaminophen, Dexamethasone, Diphenhydramine - Recurrent Acute Leukemia, Recurrent B Acute Lymphoblastic Leukemia | Phase 1 | Completed | City of Hope Medical Center | 13 | 2020-11-18 | 2026-01-28 |
| Fructooligosaccharides in Treating Patients With Blood Cancer Undergoing Donor Stem Cell Transplant Fructooligosaccharide, Laboratory Biomarker Analysis - Hematopoietic and Lymphoid Cell Neoplasm, Recurrent Hematologic Malignancy | Phase 1 | Completed | Stanford University | 15 | 2016-06-01 | 2021-03-23 |
| Ipilimumab or Nivolumab in Treating Patients With Relapsed Hematologic Malignancies After Donor Stem Cell Transplant Ipilimumab, Laboratory Biomarker Analysis, Nivolumab - Allogeneic Hematopoietic Stem Cell Transplant Recipient, Myeloproliferative Neoplasm | Phase 1 | Completed | National Cancer Institute (NCI) | 71 | 2013-05-16 | 2021-06-24 |
Hematologic Neoplasms (3) · Hodgkin Disease (2) · Leukemia, Myelogenous, Chronic, BCR-ABL Positive (2) · Blastic Plasmacytoid Dendritic Cell Neoplasm (1) · Burkitt Lymphoma (1) · Leukemia, Hairy Cell (1) · Leukemia, Lymphocytic, Chronic, B-Cell (1) · Leukemia, Myeloid, Acute (1) · Lymphoma, Non-Hodgkin (1) · Mastocytosis, Systemic (1) · Multiple Myeloma (1) · Myelodysplastic Syndromes (1) · Myeloproliferative Disorders (1) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (1) · Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (1)
Hematologic Diseases (3) · Hemic and Lymphatic Diseases (3) · Neoplasms (3) · Neoplasms by Site (3) · Bone Marrow Diseases (2) · Chronic Disease (2) · Disease Attributes (2) · Immune System Diseases (2) · Immunoproliferative Disorders (2) · Leukemia (2) · Leukemia, Lymphoid (2) · Leukemia, Myeloid (2) · Lymphatic Diseases (2) · Lymphoma (2) · Lymphoproliferative Disorders (2)
Acetaminophen (1) · CTLA-4 Antigen (1) · Calcium Dobesilate (1) · Dexamethasone (1) · Diphenhydramine (1) · Ibuprofen (1) · Ipilimumab (1) · Nivolumab (1) · Ranitidine (1) · auricularum (1) · dexamethasone 21-phosphate (1) · dexamethasone acetate (1) · fructooligosaccharide (1)
City of Hope Medical Center (1) · National Cancer Institute (NCI) (1) · Stanford University (1)
United States (3)
Andrew Rezvani (1) · Ibrahim T Aldoss (1) · Matthew S Davids (1) · Tessa Andermann (1)
PMID 27410923, PMID 32478814, PMID 33720354, PMID 35622074
P30CA006516 (1), P30CA033572 (1), P30CA124435 (1), R01CA183559 (1), U01CA062490 (1), UM1CA186709 (1)